• Je něco špatně v tomto záznamu ?

Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1

I. Trsova, A. Hrustincova, Z. Krejcik, D. Kundrat, A. Holoubek, K. Staflova, L. Janstova, S. Vanikova, K. Szikszai, J. Klema, P. Rysavy, M. Belickova, M. Kaisrlikova, J. Vesela, J. Cermak, A. Jonasova, J. Dostal, J. Fric, J. Musil, M. Dostalova Merkerova

. 2023 ; 17 (12) : 2565-2583. [pub] 20230717

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24000540

Grantová podpora
20-19162S Grantová Agentura České Republiky
00023736 Ministerstvo Zdravotnictví Ceské Republiky
RVO 61388963 Ústav organické chemie a biochemie Akademie věd České republiky

Mutations in the splicing factor 3b subunit 1 (SF3B1) gene are frequent in myelodysplastic neoplasms (MDS). Because the splicing process is involved in the production of circular RNAs (circRNAs), we investigated the impact of SF3B1 mutations on circRNA processing. Using RNA sequencing, we measured circRNA expression in CD34+ bone marrow MDS cells. We defined circRNAs deregulated in a heterogeneous group of MDS patients and described increased circRNA formation in higher-risk MDS. We showed that the presence of SF3B1 mutations did not affect the global production of circRNAs; however, deregulation of specific circRNAs was observed. Particularly, we demonstrated that strong upregulation of circRNAs processed from the zinc finger E-box binding homeobox 1 (ZEB1) transcription factor; this upregulation was exclusive to SF3B1-mutated patients and was not observed in those with mutations in other splicing factors or other recurrently mutated genes, or with other clinical variables. Furthermore, we focused on the most upregulated ZEB1-circRNA, hsa_circ_0000228, and, by its knockdown, we demonstrated that its expression is related to mitochondrial activity. Using microRNA analyses, we proposed miR-1248 as a direct target of hsa_circ_0000228. To conclude, we demonstrated that mutated SF3B1 leads to deregulation of ZEB1-circRNAs, potentially contributing to the defects in mitochondrial metabolism observed in SF3B1-mutated MDS.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24000540
003      
CZ-PrNML
005      
20240213093237.0
007      
ta
008      
240109s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/1878-0261.13486 $2 doi
035    __
$a (PubMed)37408496
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Trsova, Iva $u Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $u Department of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czech Republic
245    10
$a Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1 / $c I. Trsova, A. Hrustincova, Z. Krejcik, D. Kundrat, A. Holoubek, K. Staflova, L. Janstova, S. Vanikova, K. Szikszai, J. Klema, P. Rysavy, M. Belickova, M. Kaisrlikova, J. Vesela, J. Cermak, A. Jonasova, J. Dostal, J. Fric, J. Musil, M. Dostalova Merkerova
520    9_
$a Mutations in the splicing factor 3b subunit 1 (SF3B1) gene are frequent in myelodysplastic neoplasms (MDS). Because the splicing process is involved in the production of circular RNAs (circRNAs), we investigated the impact of SF3B1 mutations on circRNA processing. Using RNA sequencing, we measured circRNA expression in CD34+ bone marrow MDS cells. We defined circRNAs deregulated in a heterogeneous group of MDS patients and described increased circRNA formation in higher-risk MDS. We showed that the presence of SF3B1 mutations did not affect the global production of circRNAs; however, deregulation of specific circRNAs was observed. Particularly, we demonstrated that strong upregulation of circRNAs processed from the zinc finger E-box binding homeobox 1 (ZEB1) transcription factor; this upregulation was exclusive to SF3B1-mutated patients and was not observed in those with mutations in other splicing factors or other recurrently mutated genes, or with other clinical variables. Furthermore, we focused on the most upregulated ZEB1-circRNA, hsa_circ_0000228, and, by its knockdown, we demonstrated that its expression is related to mitochondrial activity. Using microRNA analyses, we proposed miR-1248 as a direct target of hsa_circ_0000228. To conclude, we demonstrated that mutated SF3B1 leads to deregulation of ZEB1-circRNAs, potentially contributing to the defects in mitochondrial metabolism observed in SF3B1-mutated MDS.
650    _2
$a lidé $7 D006801
650    _2
$a sestřihové faktory $x genetika $7 D000072260
650    _2
$a kruhová RNA $x genetika $7 D000079962
650    12
$a myelodysplastické syndromy $x genetika $7 D009190
650    _2
$a mutace $x genetika $7 D009154
650    12
$a akutní myeloidní leukemie $7 D015470
650    _2
$a transkripční faktory $x genetika $7 D014157
650    _2
$a fosfoproteiny $x genetika $7 D010750
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hrustincova, Andrea $u Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Krejcik, Zdenek $u Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Kundrat, David $u Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Holoubek, Aleš $u Department of Proteomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Staflova, Karolina $u Department of Biochemistry, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Janstova, Lucie $u Department of Modern Immunotherapy, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $u Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Vanikova, Sarka $u Department of Immunomonitoring and Flow Cytometry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Szikszai, Katarina $u Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Klema, Jiri $u Department of Computer Science, Czech Technical University, Prague, Czech Republic
700    1_
$a Rysavy, Petr $u Department of Computer Science, Czech Technical University, Prague, Czech Republic
700    1_
$a Belickova, Monika $u Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Kaisrlikova, Monika $u Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Vesela, Jitka $u Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Cermak, Jaroslav $u Laboratory of Anemias, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Jonasova, Anna $u First Department of Medicine, General University Hospital, Prague, Czech Republic
700    1_
$a Dostal, Jiri $u Department of Biochemistry, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Fric, Jan $u Department of Modern Immunotherapy, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $u International Clinical Research Center of St. Anne's University Hospital (FNUSA-ICRC), Brno, Czech Republic
700    1_
$a Musil, Jan $u Department of Immunomonitoring and Flow Cytometry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Dostalova Merkerova, Michaela $u Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $1 https://orcid.org/0000000263459180 $7 xx0164071
773    0_
$w MED00167281 $t Molecular oncology $x 1878-0261 $g Roč. 17, č. 12 (2023), s. 2565-2583
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37408496 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213093234 $b ABA008
999    __
$a ok $b bmc $g 2049287 $s 1210234
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 17 $c 12 $d 2565-2583 $e 20230717 $i 1878-0261 $m Molecular oncology $n Mol Oncol $x MED00167281
GRA    __
$a 20-19162S $p Grantová Agentura České Republiky
GRA    __
$a 00023736 $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a RVO 61388963 $p Ústav organické chemie a biochemie Akademie věd České republiky
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Možnosti archivace